A Lipoxin A₄ Analog Ameliorates Blood–Brain Barrier Dysfunction and Reduces MMP-9 Expression in a Rat Model of Focal Cerebral Ischemia–Reperfusion Injury

Author： Wu Yan Wang Yan-Ping Guo Peipei Ye Xi-Hong Wang Jie Yuan Shi-Ying Yao Shang-Long Shang You

Publisher： Humana Press, Inc

ISSN： 0895-8696

Source： Journal of Molecular Neuroscience, Vol.46, Iss.3, 2012-03, pp. : 483-491

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

LXA₄ methyl ester (LXA₄ME), a lipoxin A₄ analog, reduces ischemic insult in the rat models of transient or permanent cerebral ischemic injury. We investigated whether LXA₄ME could ameliorate blood–brain barrier (BBB) dysfunction after stroke by reducing matrix metalloproteinase (MMP)-9 expression. Adult male rats were subjected to 2-h middle cerebral artery occlusion (MCAO) followed by 24-h reperfusion. Brain infarctions were detected by triphenyltetrazolium chloride (TTC) staining. BBB dysfunction was determined by examining brain edema and Evans Blue extravasation. Temporal expression of MMP-9 was determined by zymography and Western blot. The presence of tissue inhibitors of metalloproteinase-1 (TIMP-1) was also determined by Western blot in tissue protein sample. Brain edema and Evans Blue leakage were significantly reduced after stroke in the LXA₄ME group and were associated with reduced brain infarct volumes. MMP-9 activity and expression were inhibited by LXA₄ME after stroke. In addition, LXA₄ME significantly increased TIMP-1 protein levels. Our results indicate that LXA₄ME reduces brain injury by improving BBB function in a rat model of MCAO, and that a relationship exists between BBB permeability and MMP-9 expression following ischemic insult. Furthermore, these results suggest that LXA₄ME-mediated reduction of MMP-9 following stroke are attributed to increased TIMP-1 expression.